ClinConnect ClinConnect Logo
Search / Trial NCT03842592

Ventricular Arrhythmia After Myocarditis in Sportsman

Launched by UNIVERSITY HOSPITAL, ANGERS · Feb 12, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Ventricular Arrhythmia After Myocarditis in Sportsman," is investigating how often athletes experience irregular heartbeats, known as ventricular arrhythmia, after suffering from a condition called myocarditis. Myocarditis is an inflammation of the heart muscle that can occur following a viral infection. The study will involve 50 patients aged between 65 and 74 who have been diagnosed with acute myocarditis. To participate, individuals must have experienced chest pain and have specific test results confirming their condition. They should also be active in sports, engaging in physical activity for at least 4 hours a week.

Participants in this trial will undergo regular heart monitoring using an ECG Holter device and a treadmill stress test over the course of one year. This means they will be wearing a small device to track their heart's rhythm continuously and will also perform a physical exercise test to see how their heart responds. The study is currently recruiting participants, and it is essential that individuals do not have other heart conditions or certain contraindications that would prevent them from undergoing the required tests. This research aims to better understand the effects of myocarditis on athletes’ heart health, helping to improve care and outcomes for those affected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • acute myocarditis, diagnosed on the association of (a) recent viral infection (upper airway, gastro-intestinal) , (b) troponin increase, and (c) chest pain AND myocarditis confirmed by cardiac magnetic resonance 2 out of 3 Lake Louise criteria, either T2 hypersignal, early enhancement or late gadolinium enhancement.
  • regular physical activity, recreational or competitive: \>=4 hours weekly
  • written informed consent
  • Exclusion Criteria:
  • coronary artery disease
  • acute inflammatory cardiomyopathy (sarcoidosis, fulminant myocarditis, Tako Tsubo, eosinophilic myocarditis, Lyme disease)
  • history of myocarditis
  • contra-indication to cardiac MRI
  • patient unable to perform a treadmill stress test

About University Hospital, Angers

The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.

Locations

Rennes, , France

Angers, , France

Brest, , France

Paris, , France

Patients applied

0 patients applied

Trial Officials

Loïc BIERE, MD PhD

Principal Investigator

Department of Cardiology, University Hospital of Angers (France)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials